Therapeutic targeting of neuroimmune mechanisms in neurodegeneration - Nature Reviews Drug Discovery
Neuroimmune interactions shape neurodegenerative disease progression. This Review examines how microglia integrate signals from central and peripheral immune cells, outlines emerging therapeutic targe...
BARI’s Andrew Yang breaks down how immune cells in the brain fuel neurodegeneration and what we can target to stop it. From microglial states to complement and inflammasomes, this review maps therapies that could help aging brains stay sharp longer. go.nature.com/4096fGg
#aging #neuroscience
03.03.2026 22:24
👍 1
🔁 1
💬 0
📌 0
New out in Cell! Bari’s Saul Villeda shows how a liver factor from exercise (GPLD1) rejuvenates brain barriers, clears AD gunk, and boosts memory in old mice. By hitting specific vessel proteins, it mimics workout perks. Promising for fighting dementia! #aging #neuroscience
27.02.2026 22:46
👍 0
🔁 0
💬 1
📌 0
BARI’s Michelle Arkin explores how tiny glues can calm overactive proteins in the pathways that control cell growth, key for cancer and growth disorders. As we age, these signals can mess up, so this might lead to ways to protect our brains and bodies from decline. #aging #cancer
26.02.2026 20:58
👍 0
🔁 0
💬 1
📌 0
BARI’s Andrew Yang unpacks how hypertension quietly injures the brain via AngII long before pressure rises. Early hits to endothelial cells, oligodendrocyte precursors, and inhibitor neurons, all independent of blood pressure. Strong implications for better dementia prevention strategies.
19.02.2026 18:28
👍 1
🔁 1
💬 1
📌 0
Genetic and Carcinogenic Risks of Radiotherapy for Nonmalignant Diseases
Radiotherapy is a valuable treatment option for a variety of nonmalignant diseases. As the indications for low-dose radiotherapy to benign conditions …
Key review by BARI member Jean Nakamura: Low-does radiotherapy for nonmalignant issues has low carcinogenic risk, particularly in older populations where these ailments hit hardest. Age, dose, & genetics matter too, read more here: www.sciencedirect.com/science/arti...
04.02.2026 16:51
👍 1
🔁 1
💬 0
📌 0
Neil Risch and his BARI team have a paper out in AJHG: Predicted loss-of-function variants linked to serious diseases often don’t show up as expected in big biobanks. Why? Residual activity from the variant allele keeps some function going (leaky penetrance).
28.01.2026 16:18
👍 2
🔁 2
💬 1
📌 0
What a whirlwind at #JPM2026! Grateful for the inspiring chats, new ideas, and connections that make this field so exciting. From BARI in SF: thanks for coming, safe travels home, and let’s keep pushing geroscience forward together! #agingresearch
16.01.2026 17:22
👍 1
🔁 1
💬 0
📌 0
What if lowering triglycerides could help you survive low oxygen and age better? New EMBO Reports from BARI member Dengke Ma & team explores this conserved mechanism: from arctic ground squirrel brain cells to C. elegans, reducing lipid biosynthesis protects mitochondria and extends life.
13.01.2026 23:11
👍 2
🔁 1
💬 1
📌 0
Well done to Tien Peng and team – exciting new paper out in Cell Stem Cell! The study shows how certain senescent fibroblasts drive metabolic reprogramming in lung adenocarcinoma and demonstrates that targeting them with an HSP90 inhibitor shrinks tumors.
07.01.2026 19:33
👍 1
🔁 1
💬 1
📌 0